Drugs Made In America Acquisition (DMIIU) Total Current Liabilities (2024 - 2026)
Drugs Made In America Acquisition (DMIIU) posted Total Current Liabilities of $644,574 for Q2 2026.
Analysis
Drugs Made In America Acquisition (DMIIU) Total Current Liabilities (2024 - 2026) Analysis & Trends
At the end of FY2025, Drugs Made In America Acquisition's Total Current Liabilities came in at $300,864, up 18.1% from FY2024.
- In prior years, Drugs Made In America Acquisition's Total Current Liabilities was $254,783 in FY2024.
- Quarterly Total Current Liabilities has run from a low of $254,783 in Q4 2024 to a high of $677,345 in Q3 2025 over five years.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 644,574.00 |
| Dec 31, 2025 | 300,864.00 |
| Sep 30, 2025 | 677,345.00 |
| Dec 31, 2024 | 254,783.00 |
API Access
Drugs Made In America Acquisition Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DMIIU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "DMIIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DMIIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();